Abstract. Since the first description of human fragile sites (FS) more than 40 years ago, a variety of substances were reported to induce chromosomal breaks at non-random, breakage-prone regions. According to information available from human genome browsers aphidicolin, an inhibitor of DNA replication induces 77 of 88 known common FS. However, in the literature additional FS are reported, which are also, at least in part, inducible by aphidicolin. To the best of our knowledge, here we present the first and largest ever done systematic, whole genome-directed and comprehensive screening for aphidicolin-inducible breakage-prone regions. The study was performed on stimulated peripheral blood lymphocytes of 3 unrelated healthy individuals. Twenty-five thousand metaphase spreads were analyzed and overall 22,537 FS located in 230 different loci were recorded. Sixtyone of those FS were never observed before and 52 were already previously reported but not included in genome browsers and yet verified. Interestingly, aphidicolin was able to induce all types of rare and common FS, suggesting that these breakage-prone regions are less dependent on the inducing chemicals than originally supposed. Overall, we provide the first comprehensive genome wide map for FS and studied possible correlations of chromosome length and GTG-banding level with FS-frequency. To handle FS better in future, an extension of the already existing alphabetical nomenclature for FS on single chromosomes is suggested.
Introduction
The first description of human fragile sites (FS) dates back more than 40 years (1), and the term fragile site was introduced by Magenis five years later (2) . Since that time fragile sites continued as an active area of research in cytogenetics and their definition and classification was subject for several controversies with the increasing knowledge (3, 4) . Today FS are understood as specific loci that preferentially exhibit gaps and break on metaphase chromosomes following partial inhibition of DNA synthesis. Rare FS are present in a small proportion of individuals and are inherited in a Mendelian manner. In contrast, common FS are present in all individuals and represent the largest class of FS (5) . A number of substances are in use to induce common FS e.g. the bromodeoxyuridine (BrdU) or 5-azacytidine (5-azaC) (5, 6) . Common FS are also induceable by aphidicolin that acts as an inhibitor of DNA polymerase · and Û (7) . Common FS are part of the normal mammalian chromosome structure. With a frequency of >5% in normal population they are usually not associated with disease, except for a possible correlation of some FS with cancer-related breakpoints (e.g. 5, 7, 8, 9) or a molecular cytogenetic co-localization with breakpoints in Fanconi anemia patients (10) .
According to the present knowledge, only 77 of 88 common FS listed in human genome browsers like NCBI (http://www.ncbi.nlm.nih.gov/) are induceable by aphidicolin. The three most frequently observed such FS are FRA3B in 3p14, FRA16D in 16q23 and FRAXB in Xp22. Therefore, it is not surprising that they are also part of the up to now 22 molecular characterized common FS: FRA1H, FRA1E, FRA2G, FRA3B, FRA4F, FRA6E, FRA6F, FRA7E, FRA7G, FRA7H, FRA7K, FRA7I, FRA8C, FRA9E, FRA9G, FRA11E, FRA11F, FRA11G, FRA13A, FRA16D, FRA18C and FRAXB. Interestingly, not all common FS are necessarily detectable in only one individual. Additionally, differences in the observable FS-frequency within different individuals are well known (11, 12) . Besides these 88 official, database-annotated common FS others were observed and reported, including six recently reported new sites, particularly FRA4F (13) , FRA7K (14) , FRA6H (15) , FRA9G (16) , FRA13E (15) and FRA18C (17) .
Thus, with a systematic genome-wide screening for aphidicolin inducible FS in lymphocytes of 3 unrelated healthy individuals here the question should be solved which regions of the human genome are really breakage prone and to what extent they are affected when applying aphidicolin. Twentyfive thousand metaphase spreads presenting 22,537 break events were analyzed by cytogenetics. As a result, 61 new, by now unreported and unclassified FS were detected and the existence of 52 further FS (18, 19) was proven.
Materials and methods

Cytogenetics and induction of FS.
Peripheral blood lymphocytes from three unrelated, healthy persons with normal female karyotype were studied (proband I, II and III). Proband I and II were Caucasian and proband III Caucasian-Asian in origin. Using cytogenetic standard protocols lymphocyte cultures were incubated for 72 h at 37˚C in RPMI medium supplemented with 10% fetal calf serum and 2% phytohemoagglutinin. Aphidicolin (0.2 μM) dissolved in dimethylsulfoxide was added 24 h before harvesting (20) . Colcemid (0.04 μg/ ml) was added 2 h before culture termination. Chromosome preparation was done according to standard protocols (21) . Additionally lymphocytes from all three subjects were cultivated without aphidicolin and 100 metaphase spreads were evaluated, each, as negative controls, without finding any spontaneous break events. The chromosomes were banded by diamidinophenylindol (DAPI) and evaluation was done using ISIS software (MetaSystems, Altlussheim, Germany) based inverted DAPI-banding.
The 25,000 analyzed metaphase spreads were categorized according to their band level in 300-350, 400-500, 550-650 and >650 bands per haploid karyotype. Fifty-eight percent of the metaphase spreads were arrested at a 400-500 band level, 29% at 550-650, 11% at 300-350 and 2% at a band level of >650.
A chromosomal lesion was counted when it appeared as a chromatide or chromosome gap or break according to ISCN 2009 (22) . A chromosomal site was determined to be a fragile site when it appeared more than once in this study or was reported before elsewhere in the literature.
Results
New aphidicolin-induced FS.
A total of 25,000 metaphase spreads from three female subjects were analyzed after aphidicolin-induced lymphocyte culture. Overall, cytogenetic analysis revealed 22,537 break-events, i.e. 0.91 breaks per metaphase spread. Two hundred and thirty different FS including 61 until now not reported break-prone regions could be described (Table I , entries in bold, and Figs. 2 and 3). A FS was included here as new in case it was observed in this study at least twice. If a break-event was observed at least once in this study and also previously reported as FS it was also included into the 230 ones described here.
The mean frequency of all FS detected in this study was 0.279% and only 21 out of 230 detected FS appeared with a frequency over 1%. In contrast 92 specific FS have a frequency between 0.1 and 1% and the main part of 109 FS is expressed between 0.009 and 0.099% (Table I) . The most frequently observed FS were FRA3B (14.153%), FRA16D (7.576%), FRAXB (5.494%), FRA2H (3.905%), FRA1M (3.333%) and FRA1I (2.299%) whereas FS that were described before and detected only once in this study had a frequency of 0.004% like FRA8F and FRA17D.
Additionally, single-break events were observed in the current study and not described in literature before. These breaks were not rated as new FS. In detail these were 1p34 (proband II), 2q14.2-14.3 (proband II), 3q23 (proband III), 4q32 (proband II), 15q24 (proband II), 20q13.3 (proband I) and 21q11.2 (proband I). Aphidicolin was able to induce different types of known rare and common FS that were also classified as 5-azacytidine, BrdU, folate sensitive and distamycin type before (Table I) .
Frequency of FS per metaphase spread and per haploid band level. Not surprisingly the highest amount of breaks per metaphase were found in the highest band levels (>650: 3-12; 550-650: 3-8) compared to 300-350 and 400-500 band level with 1-4 and 2-5 breaks per metaphase, respectively.
Frequency of FS in different individuals.
The FS-frequencies found in the three different studied individuals are detailed in Table I . Interindividual frequency differences for the expression of FS were found. As typical example for individualspecific FS inducibility results obtained for chromosome 10 are summarized in Fig. 1 . Especially proband III expressed the highest rate of chromosome 10-specific FS while proband II showed here an extremely low rate and e.g. no expression of FRA10K. Overall, 41% of all here detected FS were found in proband I, 38% in proband III and only 21% in proband II. Strong FS-expression variation rates were also found e.g. for FRA1I, FRA2J, FRA4C, FRA4H, FRA6B, FRA10F and FRA16C. However, beside these strong variations, there were also sites with practically identical expression in all three studied subjects, such as FRA1A, FRA3C or FRA11C (Table I) . Figs. 2 and 3 the breakprone areas are almost equally distributed along each chromosome. Table II Of the FS, 24.5% are located in GTG dark bands, 62% in light bands, 5% in centromeres and 8.5% at the boarder of light and dark bands. The major part of breaks result from chromatide breaks and only a small portion show chromosome breaks or reunions.
Distribution of FS. As shown in
Nomenclature of FS.
The nomenclature of FS is chromosomespecific and starts with the abbreviation FRA followed by chromosome number and a capital letter according to the appearance of the FS description from pter to qter, starting from A to Z e.g. FRA1A in 1p36. In accordance with these rules, the here reported new FS and also recently reported FS that were not included in human genome browsers before were added to the existing 88 genome browser entries (Table I and Fig. 3 ).
Discussion
Frequency of FS. The common classification of FS is based on their induction with specific chemicals or frequencies in the population. The latter is divided into common and rare FS. Common FS are thought to be part of the normal chromosome structure and can be expressed in every individual (11) . Nevertheless, they were also differentially expressed between different individuals, ethnic groups, sex and inducibility (12, 19, 20, 23, 24, 25) . According to the literature, the most frequently-detected FS are FRA3B (3p14.2) and FRA16D (16q23.2), which was confirmed in the current study. Even within the three investigated individuals the frequencies for those two FS were almost the same. Contrary, it is known that not all common FS were inducible in every individual (26) . This could also be shown in this study; although a huge number of metaphases were analyzed certain FS were exclusively observed only in one of the investigated test persons e.g. FRA17D (Table I) . Additionally, most FS vary in their inter-individual frequency; examples are given in Fig. 1 and Table I . Only a few authors discuss the ethnic influence on FS expression (27) . In this study proband III was CaucasianAsian descent whereas probands I and II were of Caucasian origin. Inter-individual frequency variations in FS-expression were also observed in other mammals like the mouse (28) and also between different tissues (29, 30) . Although aphidicolin-induced FS were previously studied, for a closer Also shown are FS that were not included in the genome browser but described before. For each site the cytoband is given and an arrow indicates the FS. +, FS that might be larger and fused with a neighbor FS; green frame, taken from (37); blue frame, taken from (19); olive frame, taken from (34); brown frame, taken from (38); purple frame, taken from (29); red frame, single break events in the current study. Table I . Summary of all known and newly described aphidicolin-induced FS analyzed in 25,000 metaphase spreads with the extended nomenclature, cytogenetic localization, absolute numbers in different band levels (300-350, 400-450, 550-650, >650 bands per haploid karyotype) for three different subjects (I, II and III) and the frequency of every FS after aphidicolin induction in the current study. Cytogenetic III  I  II  III  I  II III  I  II  III  I  II  ∑ (all  Frequency  localization subjects in % (all and band subjects and levels) band levels) Table I . Continued. Cytogenetic III  I  II  III  I  II III  I  II  III  I  II  ∑ (all  Frequency  localization subjects in % (all and band subjects and levels) band levels) Table I . Continued. Cytogenetic III  I  II  III  I  II III  I  II  III  I  II  ∑ (all  Frequency  localization subjects in % (all and band subjects and levels) band levels) --------------------------------------------------------------------------------------------------- Table I . Continued. Cytogenetic  III  I  II III  I  II  III  I  II III  I  II  ∑ (all  Frequency  localization  subjects  in % (all  and band  subjects and  levels) band levels) ---------------------------------------------------------------------------------------------------- Table I . Continued.
-----------------------------------------------------------------------------------------------------Number of FS per band level ---------------------------------------------------------300-350 400-500 550-650 >650 -----------------------------------------------All FS
-
----------------------------------------------------------------------------------------------------Number of FS per band level ---------------------------------------------------------
300-350 400-500 550-650 Cytogenetic  III  I  II  III  I  II  III  I  II III  I  II  ∑ (all  Frequency  localization subjects in % (all and band subjects and levels) band levels) ---------------------------------------------------------------------------------------------------- 
look on inter-individual and/or ethnic influences on FS frequency variation, larger population studies on comparable conditions would be needed.
New FS. The current study identified 61 until now not reported FS and 7 unique break events that were not reported before. The frequency of these new sites varies between 0.009% (FRA14G) and 0.231% (FRA3E). Other, wellestablished aphidicolin-induced sites range from 0.067% (FRA1E) to 14.153% (FRA3B), indicating that the newly described sites have a low expression rate and therefore were not detected or reported previously. Although some authors stress the necessity for fragility to be defined as a statistical phenomenon (e.g. 12,31), the main part of fragile sites is expressed in low frequencies, sometimes limited to single individuals and depends on several other factors such as aphidicolin concentration, gender or ethnic origin. Furthermore, complicating is the definition of a fragile site since several authors use different definitions or count also single breaks as fragile sites (11, 30, 32) . Therefore, we decided to use a more practical definition where all sites are included that were observed more than once in this study or were already published elsewhere to minimize false positive random background breaks. Only little is known about the influence of local chromatin structure for FS expression. Obviously FS are overrepresented in GTG light bands. This holds also true for the new identified FS, 59% of which appears in GTG-light bands. Recently, an unusual chromatin structure or failure of chromatin condensation was postulated as inductors of FS (33) . Table I . Continued. Cytogenetic III  I  II  III  I  II  III  I  II  III  I  II  ∑ (all  Frequency  localization subjects in % (all and band subjects and levels) band levels) ---------------------------------------------------------------------------------------------------- (19) with new nomenclature, h new identified FS but only one time recorded and not included in the nomenclature, i FS that were already assigned to the nomenclature by other authors but not included in genome browsers. Table II . Number of FS and average distance in Mb between FS for single chromosomes. Chromosome  13  14  15  16  17  18  19  20  21 22 
-----------------------------------------------------------------------------------------------------
Nomenclature. The common nomenclature system for FS includes the abbreviation FRA followed by chromosome number and a letter starting with A arranged in a linear order from pter to qter. Chromosome and chromatide breaks in this study were counted as new FS and included in the nomenclature when they were observed more than one time. Seven unique breaks were also recorded ( Fig. 2 and Table I ), but not included in the nomenclature (Fig. 3 and Table I ).
The current study identified 230 compared to only 129 rare and common FS, which are listed in the NCBI genome browser. Even more complicating is the fact that 15 of these sites map at the same cytogenetic region but have different names because of different ways of induction (NCBI genome browser, Fig. 3 ). Additionally, 52 identified and in parts mapped FS were already published, but not included in the current genome browser versions (13, 14, 15, 16, 17, 19, 23, 34) . Most of these sites were confirmed in this study which underlines their eligibility to be appreciated as FS.
FS classification. FS are commonly classified in rare FS that can be induced by folate absence, distamycin A, 5-fluorodeoxyuridin or BrdU, and in common FS inducible by aphidicolin, BrdU or 5-azacytidine. In the current study exclusively aphidicolin induction was used, and surprisingly nearly every type of rare and common FS could be recorded. Overall, this makes the classification in rare and common FS at least questionable. The main reason to explain this surprising finding might be a relative small amount of FS studied in near-comparable studies. Differences to literature data were also observed in the frequency of single sites when the induction was done in a different way (Table III) .
Based on frequency differences within expression rates of so-called common FS from 14.153% (FRA3B, this study) to 0.004% (e.g. FRA17D, this study) some authors (12, 24, 28) suggested a classification in high (HFFS) and low frequency FS (LFFS). This classification seems to be more reliable than the historical division in common and rare FS. Also a classification based on the chemical induction of FS seems questionable; particularly as in this study every type of FS could be induced by aphidicolin.
Conclusion. Location of FS seems to be independent of the chemical agents used. Thus, a classification in different induction types is no longer warranted. According to Hecht et al (4) and others we prefer a classification of high and low frequency FS. In order to prevent double naming of FS in the same cytogenetic location, caused historically by different modes of induction, an expanded definition of FS into fragile regions is helpful as it becomes more and more clear from molecular mapping data that especially aphidicolin inducible FS do not break at defined sequences but in breakage-prone regions up to 10 Mb (35, 36) where the break is most likely to appear.
